[1] M.Z. Cader, A. Kaser, Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation,
Gut,
2013,
62, 1653-1664. [
Crossref], [
Google Scholar], [
Publisher]
[2] A.N. Ananthakrishnan, Epidemiology and risk factors for IBD,
Nature Reviews Gastroenterology & Hepatology,
2015,
12, 205-217. [
Crossref], [
Google Scholar], [
Publisher]
[3] A. Geremia, P. Biancheri, P. Allan, G.R.Corazza, A. Di Sabatino, Innate and adaptive immunity in inflammatory bowel disease,
Autoimmunity Reviews,
2014,
13, 3-10. [
Crossref], [
Google Scholar], [
Publisher]
[4] V. Annese, M. Daperno, M.D. Rutter, A. Amiot, P. Bossuyt, J. East, M. Ferrante, M. Götz, K.H. Katsanos, R. Kießlich, I. Ordás, European evidence based consensus for endoscopy in inflammatory bowel disease,
Journal of Crohn's and Colitis,
2013,
7, 982-1018. [
Crossref], [
Google Scholar], [
Publisher]
[5] G.A. Calin, M. Ferracin, A. Cimmino, G. Di Leva, M. Shimizu, S.E. Wojcik, M.V. Iorio, R. Visone, N.I. Sever, M. Fabbri, R. Iuliano, A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia,
New England Journal of Medicine,
2005,
353, 1793-1801. [
Crossref], [
Google Scholar], [
Publisher]
[7] J.D. Lewis, The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease,
Gastroenterology,
2011,
140, 1817-1826. [
Crossref], [
Google Scholar], [
Publisher]
[8] Y.M. Shastri, D. Bergis, N. Povse, V. Schäfer, S. Shastri, M. Weindel, H. Ackermann, J. Stein, Prospective multicenter study evaluating fecal calprotectin in adult acute bacterial diarrhea,
The American Journal of Medicine,
2008,
121, 1099-1106. [
Crossref], [
Google Scholar], [
Publisher]
[9] A.A. Soubières, A. Poullis, Emerging role of novel biomarkers in the diagnosis of inflammatory bowel disease,
World Journal of Gastrointestinal Pharmacology and Therapeutics,
2016,
7, 41. [
Crossref], [
Google Scholar], [
Publisher]
[10] J.A. Weber, D.H. Baxter, S. Zhang, D.Y. Huang, K. How Huang, M. Jen Lee, D.J. Galas, K. Wang, The microRNA spectrum in 12 body fluids,
Clinical chemistry,
2010,
56, 1733-1741. [
Crossref], [
Google Scholar], [
Publisher]
[11] D.G. Johnston, M.A. Williams, C.A. Thaiss, R. Cabrera-Rubio, M. Raverdeau, C. McEntee, P.D. Cotter, E. Elinav, L.A. O’Neill, S.C. Corr, Loss of microRNA-21 influences the gut microbiota, causing reduced susceptibility in a murine model of colitis,
Journal of Crohn's and Colitis,
2018,
12, 835-848. [
Crossref], [
Google Scholar], [
Publisher]
[12] S.R. Whiteoak, R. Felwick, T. Sanchez-Elsner, J.R. Fraser Cummings, MicroRNAs in inflammatory bowel diseases: paradoxes and possibilities,
Inflammatory Bowel Diseases,
2015,
21, 1160-1165. [
Crossref], [
Google Scholar], [
Publisher]
[13] R. Rameshshanker, N. Arebi, Endoscopy in inflammatory bowel disease when and why,
World Journal of Gastrointestinal Endoscopy,
2012 4, 201. [
Crossref], [
Google Scholar], [
Publisher]
[14] S.P. Travis, D. Schnell, P. Krzeski, M.T. Abreu, D.G. Altman, J.F. Colombel, B.G. Feagan, S.B. Hanauer, M. Lémann, G.R. Lichtenstein, P.R. Marteau, Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS),
Gut,
2012,
61, 535-542. [
Crossref], [
Google Scholar], [
Publisher]
[15] L. Masi, I. Capobianco, C. Magrì, I. Marafini, V. Petito, F. Scaldaferri, MicroRNAs as innovative biomarkers for inflammatory bowel disease and prediction of colorectal cancer,
International Journal of Molecular Sciences,
2022,
23, 7991. [
Crossref], [
Google Scholar], [
Publisher]
[16] L. Sun, Y. Han, H. Wang, H. Liu, S. Liu, H. Yang, X. Ren, Y. Fang, MicroRNAs as potential biomarkers for the diagnosis of inflammatory bowel disease: a systematic review and meta-analysis,
Journal of International Medical Research,
2022,
50, 3000605221089503. [
Crossref], [
Google Scholar], [
Publisher]
[17] S.S. Krishnachaitanya, M. Liu, K. Fujise, Q. Li, MicroRNAs in inflammatory bowel disease and its complications,
International Journal of Molecular Sciences,
2022,
23, 8751. [
Crossref], [
Google Scholar], [
Publisher]
[18] F. Wu, M. Zikusoka, A. Trindade, T. Dassopoulos, M.L. Harris, T.M. Bayless, S.R. Brant, S. Chakravarti, J.H. Kwon, MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2α,
Gastroenterology,
2008,
135, 1624-1635. [
Crossref], [
Google Scholar], [
Publisher]
[19] A. Paraskevi, G. Theodoropoulos, I. Papaconstantinou, G. Mantzaris, N. Nikiteas, M. Gazouli, Circulating MicroRNA in inflammatory bowel disease,
Journal of Crohn's and Colitis,
2012,
6, 900-904. [
Crossref], [
Google Scholar], [
Publisher]
[20] K. Schönauen, N. Le, U. von Arnim, C. Schulz, P. Malfertheiner, A. Link, Circulating and fecal microRNAs as biomarkers for inflammatory bowel diseases,
Inflammatory Bowel Diseases,
2018,
24, 1547-1557. [
Crossref], [
Google Scholar], [
Publisher]
[21] A. Atanassova, A. Georgieva, Circulating miRNA-16 in inflammatory bowel disease and some clinical correlations–a cohort study in Bulgarian patients,
European Review for Medical & Pharmacological Sciences,
2022,
26. [
Crossref], [
Google Scholar], [
Publisher]
[22] T. Tian, Y. Zhou, X. Feng, S. Ye, H. Wang, W. Wu, W. Tan, C. Yu, J. Hu, R. Zheng, Z. Chen, MicroRNA-16 is putatively involved in the NF-κB pathway regulation in ulcerative colitis through adenosine A2a receptor (A2aAR) mRNA targeting,
Scientific Reports,
2016,
6, 30824. [
Crossref], [
Google Scholar], [
Publisher]
[23] A. Habib, A. Minisi, M. Awad, A. Essa, A. Khalifa, S. Shehab-Eldeen, Serum microRNA 106 and microRNA 223 as novel biomarkers in inflammatory bowel disease,
Medical Journal of Viral Hepatitis,
2020,
5, 19-24. [
Crossref], [
Google Scholar], [
Publisher]
[24] M. Fasseu, X. Tréton, C. Guichard, E. Pedruzzi, D. Cazals-Hatem, C. Richard, T. Aparicio, F. Daniel, J.C. Soulé, R. Moreau, Y. Bouhnik, Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease,
PloS One,
2010,
5, 13160. [
Crossref], [
Google Scholar], [
Publisher]
[25] A.M. Zahm, M. Thayu, N.J. Hand, A. Horner, M.B. Leonard, J.R. Friedman, Circulating microRNA is a biomarker of pediatric Crohn disease,
Journal of Pediatric Gastroenterology and Nutrition,
2011,
53, 26-33. [
Crossref], [
Google Scholar], [
Publisher]
[26] R. Duttagupta, S. DiRienzo, R. Jiang, J. Bowers, J. Gollub, J. Kao, K. Kearney, D. Rudolph, N.B. Dawany, M.K. Showe, T. Stamato, Genome-wide maps of circulating miRNA biomarkers for ulcerative colitis,
PloS One, 2012,
7, 31241. [
Crossref], [
Google Scholar], [
Publisher]
[27] H. Wang, S. Zhang, Q. Yu, G. Yang, J. Guo, M. Li, Z. Zeng, Y. He, B. Chen, M. Chen, Circulating microRNA223 is a new biomarker for inflammatory bowel disease,
Medicine,
2016,
95, 2703. [
Crossref], [
Google Scholar], [
Publisher]
[28] A. Omidbakhsh, M. Saeedi, M. Khoshnia, A. Marjani, S. Hakimi, Micro-RNAs-106a and-362-3p in peripheral blood of inflammatory bowel disease patients,
The Open Biochemistry Journal,
2018,
12, 78. [
Crossref], [
Google Scholar], [
Publisher]
[29] K.D. Taganov, M.P. Boldin, K.J. Chang, D. Baltimore, NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses,
Proceedings of the National Academy of Sciences,
2006,
103, 12481-12486. [
Crossref], [
Google Scholar], [
Publisher]